Last update 21 Nov 2024

NK-042

Overview

Basic Info

Drug Type
Natural Killer Cell Therapies
Synonyms
Target-
Mechanism-
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Shanghai Enkai Cell Technology Co., Ltd.
Active Organization
Shanghai Enkai Cell Technology Co., Ltd.
Inactive Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with NK-042
NCT06676631 / Not yet recruitingPhase 1IIT
NK010 or NK042 Cell Injection in Combination With Rituximab in Patients With Refractory Systemic Lupus Erythematosus or Lupus Nephritis
NCT06415500 / Not yet recruitingPhase 1IIT
A Single Center, Open, Single Arm Clinical Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites
100 Clinical Results associated with NK-042
Login to view more data
100 Translational Medicine associated with NK-042
Login to view more data
100 Patents (Medical) associated with NK-042
Login to view more data
1
Literatures (Medical) associated with NK-042
01 Jan 2013Bioorganic & Medicinal Chemistry LettersQ4 · MEDICINE
Synthesis and anti-angiogenic activity of benzothiazole, benzimidazole containing phthalimide derivatives
Q4 · MEDICINE
100 Deals associated with NK-042
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmIND Approval
CN
Shanghai Enkai Cell Technology Co., Ltd.
23 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free